Ligand validation:5U7M

NAG: 2-acetamido-2-deoxy-beta-D-glucopyranose

NAG is a Ligand Of Interest in 5U7M designated by the RCSB

	Best-fitted instance in this entry
	Other instances in this entry

	Best-fitted instance in this entry
	Best-fitted PDB instances with same target (top 5)

	Best-fitted instance in this entry
	Best-fitted PDB instances with different target (top 5)

Identifier	Ranking for goodness of fit	Ranking for geometry	Real space R factor	Real space correlation coefficient	RMSZ-bond-length	RMSZ-bond-angle	Outliers of bond length	Outliers of bond angle	Atomic clashes	Stereochemical errors	Model completeness	Average occupancy
5U7M_NAG_G_624	49%	89%	0.121	0.866	0.2	0.43	-	-	0	0	100%	0.9333
5U7M_NAG_B_704	35%	87%	0.097	0.782	0.25	0.45	-	-	0	0	100%	0.9333
5U7M_NAG_G_631	22%	52%	0.092	0.706	0.47	1.35	-	2	0	0	100%	0.9333
5U7M_NAG_B_702	19%	86%	0.099	0.691	0.25	0.46	-	-	0	0	100%	0.9333
5U7M_NAG_G_611	18%	87%	0.118	0.704	0.23	0.46	-	-	0	0	100%	0.9333
5U7M_NAG_B_703	12%	90%	0.132	0.662	0.21	0.39	-	-	1	0	100%	0.9333
5U7M_NAG_G_656	6%	89%	0.1	0.533	0.21	0.42	-	-	0	0	100%	0.9333
5U7M_NAG_H_301	4%	87%	0.11	0.467	0.25	0.43	-	-	0	0	100%	0.9333
5U7M_NAG_G_646	2%	89%	0.143	0.43	0.2	0.42	-	-	0	0	100%	0.9333
5U7O_NAG_B_704	100%	88%	0.024	0.989	0.23	0.44	-	-	0	0	100%	0.9333
5FYL_NAG_G_1582	97%	55%	0.046	0.958	0.73	0.99	1	1	0	0	100%	0.9333
6MU8_NAG_G_634	84%	79%	0.083	0.943	0.24	0.62	-	1	0	0	100%	0.9333
6MU7_NAG_G_634	83%	84%	0.081	0.94	0.24	0.52	-	-	0	0	100%	0.9333
6MTN_NAG_G_634	83%	74%	0.09	0.947	0.35	0.66	-	1	0	0	100%	0.9333
3H0C_NAG_A_794	100%	56%	0.021	0.995	0.61	1.08	-	1	0	0	100%	0.9333
5LDS_NAG_B_1007	100%	67%	0.022	0.995	0.48	0.79	-	-	0	0	100%	0.9333
5O5D_NAG_A_601	100%	65%	0.022	0.994	0.32	0.99	-	1	0	0	100%	0.9333
6MUG_NAG_G_629	100%	76%	0.022	0.994	0.35	0.58	-	-	0	0	100%	0.9333
3GXM_NAG_A_498	100%	45%	0.026	0.992	0.75	1.34	-	2	0	0	100%	0.9333

RCSB PDB Core Operations are funded by the U.S. National Science Foundation (DBI-2321666), the US Department of Energy (DE-SC0019749), and the National Cancer Institute, National Institute of Allergy and Infectious Diseases, and National Institute of General Medical Sciences of the National Institutes of Health under grant R01GM157729.